Black Diamond Therapeutics (BDTX) Other Non Operating Income: 2019-2021
Historic Other Non Operating Income for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2021 value amounting to -$375,000.
- Black Diamond Therapeutics' Other Non Operating Income rose 46.20% to -$375,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$2.3 million, marking a year-over-year decrease of 80.05%. This contributed to the annual value of -$2.2 million for FY2021, which is 26.91% down from last year.
- According to the latest figures from Q4 2021, Black Diamond Therapeutics' Other Non Operating Income is -$375,000, which was up 23.31% from -$489,000 recorded in Q3 2021.
- Black Diamond Therapeutics' 5-year Other Non Operating Income high stood at $23,000 for Q4 2019, and its period low was -$1.1 million during Q3 2019.
- Over the past 3 years, Black Diamond Therapeutics' median Other Non Operating Income value was -$541,500 (recorded in 2020), while the average stood at -$499,750.
- As far as peak fluctuations go, Black Diamond Therapeutics' Other Non Operating Income surged by 46.77% in 2020, and later slumped by 7,300.00% in 2021.
- Quarterly analysis of 3 years shows Black Diamond Therapeutics' Other Non Operating Income stood at $23,000 in 2019, then tumbled by 3,130.43% to -$697,000 in 2020, then skyrocketed by 46.20% to -$375,000 in 2021.
- Its Other Non Operating Income stands at -$375,000 for Q4 2021, versus -$489,000 for Q3 2021 and -$740,000 for Q2 2021.